NXPL · NextPlat Corp · Insider Trading
The latest filing states the doubt was alleviated.
“These conditions raised substantial doubt about the Company's ability to continue as a going concern for the twelve months following the issuance of these Condensed Consolidated Financial Statements. Management has evaluated its plans to mitigate these conditions. These plans include expanding the Company's long-term care pharmacy operations, increasing 340B contract pharmacy revenue, developing additional institutional medication fulfillment contracts, and implementing identified operational efficiencies. For the six months ended June 30, 2026, operating loss decreased to approximately $1.2 million from $3.9 million, and cash used in operating activities decreased to approximately $1.5 million from $3.1 million. As of June 30, 2026, the Company had cash of approximately $11.9 million and $3.8 million of remaining availability under the ATM Program. Based on these results, management's projections of operating results and cash flows for the twelve months following issuance, and the Company's liquidity position, management has concluded that its plans, which are probable of being effectively implemented and probable of mitigating the relevant conditions, alleviate the substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-06-30 | Armas Anthony |
Director |
Award↑
|
Common Stock
(I)
|
943 |
| 2026-06-30 | Barreto Rodney |
Director |
Award↑
|
Common Stock
|
1,886 |
| 2026-06-30 | ELLENOFF DOUGLAS |
Director |
Award↑
|
Common Stock
|
1,886 |
| 2026-04-06 | Barreto Rodney |
Director |
Award↑
|
Common Stock
|
24,324 |
| 2026-04-06 | Armas Anthony |
Director |
Award↑
|
Common Stock
(I)
|
12,162 |
| 2026-04-06 | ELLENOFF DOUGLAS |
Director |
Award↑
|
Common Stock
|
24,324 |
| 2025-12-31 | Barreto Rodney |
Director |
Award↑
|
Common Stock
|
21,176 |
| 2025-12-31 | ELLENOFF DOUGLAS |
Director |
Award↑
|
Common Stock
|
21,176 |
| 2025-12-31 | Armas Anthony |
Director |
Award↑
Filing footnotes — Common Stock (Indirect)
Mr. Armas is the sole member and managing partner of Apollo Two MSO LLC and has voting and dispositive power over the reported shares. |
Common Stock
(I)
|
10,588 |
| 2025-12-05 | Phipps David |
Director, Chief Executive Officer |
Award↑
|
Common Stock
|
100,000 |
| 2025-12-05 | Bedwell Robert Phillip Jr. |
Chief Compliance Officer |
Award↑
|
Common Stock
|
40,000 |
| 2025-12-05 | Ferrio Amanda |
Chief Financial Officer |
Award↑
|
Common Stock
|
75,000 |
| 2025-10-15 | Delgado Hector |
Director |
Award↑
Filing footnotes — Common Stock (Indirect)
Mr. Delgado is the manager of Trident Warfare LLC and has voting and dispositive power over the reported shares. |
Common Stock
(I)
|
30,000 |
| 2025-10-15 | ELLENOFF DOUGLAS |
Director |
Award↑
|
Common Stock
|
20,000 |
| 2025-10-15 | Armas Anthony |
Director |
Award↑
Filing footnotes — Common Stock (Indirect)
Mr. Armas is the sole member and managing partner of Apollo Two MSO LLC and has voting and dispositive power over the reported shares. |
Common Stock
(I)
|
30,000 |
| 2025-09-26 | Phipps David |
Director, Chief Executive Officer |
Award↑
|
Common Stock
|
200,000 |
| 2024-10-01 | Fernandez Charles M. |
Director, Chairman & CEO, 10% Owner |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
In connection with the Merger, the Report Person received stock options to acquire 233,682 shares of the Issuer's common stock in exchange for stock options to acquire 157,203 shares of Progressive Care Inc. The options are fully vested. |
Employee Stock Option (right to buy)
|
233,682 |
| 2024-10-01 | Barreto Rodney |
Director |
Award↑
Filing footnotes — Stock Option (right to buy) (Direct)
In connection with the Merger, the Reporting Person received stock options to acquire 186,946 shares of the Issuer's common stock in exchange for stock options to acquire 125,762 shares of Progressive Care Inc. The stock options are fully vested. |
Stock Option (right to buy)
|
186,946 |
| 2024-10-01 | HOUGH JERVIS |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
On October 1, 2024, the Reporting Person received 127,675 shares of the Issuer's common stock in exchange for 85,890 shares of Progressive Care Inc. in connection with the merger of Progressive Care Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq. |
Common Stock
|
127,675 |
| 2024-10-01 | Barreto Rodney |
Director |
Award↑
Filing footnotes — Common Stock (Indirect)
On October 1, 2024, the Reporting Person received 638,522 shares of the Issuer's common stock in exchange for 429,547 shares of Progressive Care Inc. in connection with the merger of Progressive Care Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq. Mr. Barreto is the president of RLB Market Investments, LLC and has voting and dispotive power over the reported securities. |
Common Stock
(I)
|
594,484 |
| 2024-10-01 | Munnik Cecile |
CFO |
Award↑
Filing footnotes — Common Stock (Direct)
On October 1, 2024, the Reporting Person received 7,433 shares of the Issuer's common stock in exchange for 5,000 shares of Progressive Care Inc. in connection with the merger of Progressive Care Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq. |
Common Stock
|
7,433 |
| 2024-10-01 | Fernandez Charles M. |
Director, Chairman & CEO, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
On October 1, 2024, the Reporting Person received 27,145 shares of the Issuer's common stock in exchange for 18,261 shares of Progressive Care Inc. in connection with the merger of Progressive Care Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq. |
Common Stock
|
27,145 |
| 2024-10-01 | Munnik Cecile |
CFO |
Award↑
Filing footnotes — Employee Stock Option (right to buy) (Direct)
In connection with the Merger, the Report Person received stock options to acquire 37,163 shares of the Issuer's common stock in exchange for stock options to acquire 25,000 shares of Progressive Care Inc. The options are fully vested. Represents 75,496 stock options that are fully vested. |
Employee Stock Option (right to buy)
|
37,163 |
| 2024-10-01 | Bedwell Robert Phillip Jr. |
Chief Compliance Officer |
Award↑
Filing footnotes — Common Stock (Direct)
On October 1, 2024, the Reporting Person received 31 shares of the Issuer's common stock in exchange for 21 shares of Progressive Care Inc. in connection with the merger of Progressive Care Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq. |
Common Stock
|
31 |
| 2024-10-01 | Barreto Rodney |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
On October 1, 2024, the Reporting Person received 638,522 shares of the Issuer's common stock in exchange for 429,547 shares of Progressive Care Inc. in connection with the merger of Progressive Care Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq. |
Common Stock
|
44,038 |
| 2024-10-01 | Armas Anthony |
Director |
Award↑
Filing footnotes — Common Stock (Indirect)
On October 1, 2024, the Reporting Person received 60,566 shares of the Issuer's common stock in exchange for 40,744 shares of Progressive Care Inc. in connection with the merger of Progressive Care Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq. Mr. Armas is the sole member and managing partner of Apollo Two MSO LLC and has voting and dispositive power over the reported shares. |
Common Stock
(I)
|
60,566 |
| 2024-10-01 | Alcaine Elizabeth |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
On October 1, 2024, the Reporting Person received 60,566 shares of the Issuer's common stock in exchange for 40,744 shares of Progressive Care Inc. in connection with the merger of Progressive Care Inc. into the Issuer (the "Merger"). On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq. |
Common Stock
|
60,566 |
| 2024-10-01 | Fernandez Charles M. |
Director, Chairman & CEO, 10% Owner |
Award↑
Filing footnotes — Common Stock (Indirect)
In connection with the Merger, the Reporting Person indirectly received 687,038 shares of the Issuer's common stock in exchange for 462,185 shares of Progressive Care Inc. through eAperion Partners LLC. On the effective date of the Merger, the Issuer's Per Share Value was $1.48, which is the daily volume weighted average price of the Issuer's common stock for the 20-trading day period ended on the trading day immediately preceding the date of the Merger Agreement on Nasdaq. Mr. Fernandez is the sole member and managing partner of eAperion Partners LLC and has voting and dispotive power over the reported shares. |
Common Stock
(I)
|
687,038 |
| 2024-04-16 | Miller John Edward |
Director |
Buy↑
Filing footnotes — Common Stock (Direct)
On April 16, 2024, Mr. Miller purchased 5,000 shares of the Company's common stock in the open market at a price of $1.43 per share. |
Common Stock
|
5,000 |
| 2023-04-25 | Cusimano Louis |
Director |
Award↑
|
Stock Option
|
20,000 |
| 2023-04-25 | Miller John Edward |
Director |
Award↑
|
Stock Option
|
20,000 |
| 2023-04-25 | Carpenter Kendall W. |
Director |
Award↑
|
Stock Option
|
20,000 |
| 2023-04-25 | Delgado Hector |
Director |
Award↑
|
Stock Option
|
20,000 |
| 2023-04-25 | Fernandez Maria Cristina |
Director |
Award↑
|
Stock Option
|
20,000 |
| 2023-04-14 | Fernandez Charles M. |
Director, Chairman & CEO, 10% Owner |
Award↑
Filing footnotes — Stock Option (Indirect)
On April 14, 2023, the reporting person was granted options to purchase up to 200,000 shares of the Issuer's common stock pursuant to a Stock Option Agreement dated April 14, 2023, of which the shares of common stock vested immediately on the Grant Date. |
Stock Option
(I)
|
200,000 |
| 2023-04-07 | Munnik Cecile |
CFO |
Award↑
Filing footnotes — Stock Options (Direct)
The options were granted pursuant to the Issuer's 2021 Incentive Award Plan. On April 7, 2023, Ms. Munnik entered into a Stock Option Agreement with the Issuer pursuant to which Ms. Munnik was granted an option to purchase 5,000 shares of Issuer's common stock, of which one third of the shares of common stock vest immediately on the Grant Date, with options to purchase an additional third of the shares of common stock vesting on the one-year anniversary of the Grant Date, and options to purchase the remaining third of the shares of common stock vesting on the second-year anniversary of the Grant Date. |
Stock Options
|
5,000 |
| 2023-04-07 | Fernandez Charles M. |
Director, Chairman & CEO, 10% Owner |
Award↑
Filing footnotes — Common Stock (Indirect)
On April 7, 2023, the reporting person's wife, and employee of the Issuer, entered into a Restricted Stock Award Agreement with the Issuer, pursuant to which she was granted 25,000 shares of the Issuer's common stock. The restricted stock vested immediately upon issuance. Includes 3,652,667 shares of common stock held indirectly by eAperion Partners, LLC, of which Mr. Fernandez is the owner and manager. |
Common Stock
(I)
|
25,000 |
| 2023-04-07 | Munnik Cecile |
CFO |
Award↑
Filing footnotes — Common Stock (Direct)
On April 7, 2023, Ms. Munnik entered into a Restricted Stock Award Agreement with the Issuer, pursuant to which Ms. Munnik was awarded 5,000 shares of Issuer's common stock. The restricted stock vests immediately upon issuance. The options were granted pursuant to the Issuer's 2021 Incentive Award Plan. |
Common Stock
|
5,000 |
| 2023-04-07 | Fernandez Charles M. |
Director, Chairman & CEO, 10% Owner |
Award↑
Filing footnotes — Stock Option (Indirect)
The reporting person's wife, an employee of the Issuer, was granted options to purchase up to 25,000 shares of the Issuer's common stock pursuant to a Stock Option Agreement dated April 7, 2023, of which one third of the shares of common stock vested immediately on the Grant Date, with options to purchase an additional third of the shares of common stock vesting on the one-year anniversary of the Grant Date, and options to purchase the remaining third of the shares of common stock vesting on the second-year anniversary of the Grant Date. |
Stock Option
(I)
|
25,000 |
| 2023-04-07 | Bedwell Robert Phillip Jr. |
Chief Compliance Officer |
Award↑
Filing footnotes — Common Stock (Direct)
On April 7, 2023, Mr. Bedwell entered into a Restricted Stock Award Agreement with the Issuer, pursuant to which Mr. Bedwell was awarded 5,000 shares of Issuer's common stock. The restricted stock vests immediately upon issuance. The options were granted pursuant to the Issuer's 2021 Incentive Award Plan. |
Common Stock
|
5,000 |
| 2023-04-07 | Bedwell Robert Phillip Jr. |
Chief Compliance Officer |
Award↑
Filing footnotes — Stock Options (Direct)
The options were granted pursuant to the Issuer's 2021 Incentive Award Plan. On April 7, 2023, Mr. Bedwell entered into a Stock Option Agreement with the Issuer pursuant to which Mr. Bedwell was granted an option to purchase 5,000 shares of Issuer's common stock, of which one third of the shares of common stock vest immediately on the Grant Date, with options to purchase an additional third of the shares of common stock vesting on the one-year anniversary of the Grant Date, and options to purchase the remaining third of the shares of common stock vesting on the second-year anniversary of the Grant Date. |
Stock Options
|
5,000 |
| 2023-04-05 | Barreto Rodney |
Director |
Award↑
Filing footnotes — Common Stock (Indirect)
On April 3, 2023, the Compensation Committee and Board of the Issuer approved a restricted stock award for 125,000 shares of common stock to Mr. Barreto under the Issuer's 2021 Incentive Award Plan. The restricted shares were then issued on April 5, 2023. The shares are fully vested. Mr. Barreto is the president of RLB Market Investments, LLC. |
Common Stock
(I)
|
125,000 |
| 2023-04-05 | Fernandez Charles M. |
Director, Chairman & CEO, 10% Owner |
Award↑
Filing footnotes — Common Stock (Indirect)
On April 3, 2023, the Compensation Committee and Board of the Issuer approved a restricted stock award for 325,000 shares of common stock to Mr. Fernandez under the Issuer's 2021 Incentive Award Plan. The restricted shares were then issued on April 5, 2023. The shares are fully vested. Does not include 400,000 shares of restricted stock awarded on May 28, 2021, that vests in two equal tranches on the second and third year anniversaries of the grant date. Mr. Fernandez is the sole member and managing partner of eAperion Partners LLC. |
Common Stock
(I)
|
325,000 |
| 2023-04-03 | Fernandez Charles M. |
Director, Chairman & CEO, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Includes 3,652,667 shares of common stock held indirectly by eAperion Partners, LLC, of which Mr. Fernandez is the owner and manager. |
Common Stock
|
325,000 |
| 2023-02-28 | Fernandez Charles M. |
Director, Chairman & CEO, 10% Owner |
Award↑
Filing footnotes — Common Stock (Direct)
Includes 3,652,667 shares of common stock held indirectly by eAperion Partners, LLC, of which Mr. Fernandez is the owner and manager. |
Common Stock
|
39,000 |
| 2022-12-14 | Fernandez Charles M. |
Director, Chairman & CEO, 10% Owner |
Buy↑
Filing footnotes — Common Stock Warrants (Indirect)
On December 14, 2022 eAperion Partners LLC purchased 1,085,714 units from the Issuer in a private placement for $1.75 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock of the Issuer. The warrants underlying units are immediately exercisable. Mr. Fernandez is the sole member and managing partner of eAperion Partners LLC. |
Common Stock Warrants
(I)
|
1,085,714 |
| 2022-12-14 | Barreto Rodney |
Director |
Buy↑
Filing footnotes — Common Stock (Indirect)
On December 14, 2022, RLB Market Investments, LLC purchased 1,085,714 units from the Issuer in a private placement for $1.75 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock of the Issuer. The warrants underlying units are immediately exercisable. Mr. Barreto is the president of RLB Market Investments, LLC |
Common Stock
(I)
|
1,085,714 |
| 2022-12-14 | Barreto Rodney |
Director |
Buy↑
Filing footnotes — Common Stock Warrants (Indirect)
On December 14, 2022, RLB Market Investments, LLC purchased 1,085,714 units from the Issuer in a private placement for $1.75 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock of the Issuer. The warrants underlying units are immediately exercisable. Mr. Barreto is the president of RLB Market Investments, LLC |
Common Stock Warrants
(I)
|
1,085,714 |
| 2022-12-14 | Fernandez Charles M. |
Director, Chairman & CEO, 10% Owner |
Buy↑
Filing footnotes — Common Stock (Indirect)
On December 14, 2022 eAperion Partners LLC purchased 1,085,714 units from the Issuer in a private placement for $1.75 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock of the Issuer. The warrants underlying units are immediately exercisable. Mr. Fernandez is the sole member and managing partner of eAperion Partners LLC. |
Common Stock
(I)
|
1,085,714 |
| 2022-12-14 | Phipps David |
Director, Chief Executive Officer |
Buy↑
Filing footnotes — Common Stock (Direct)
On December 14, 2022, David Phipps purchased 28,500 units from the Issuer in a private placement for $1.75 per unit. Each unit consists of one share of common stock and one warrant to purchase one share of common stock of the Issuer. The warrants underlying units are immediately exercisable. |
Common Stock
|
28,500 |